Mitsu Chem Plast net profit rises 115% to ₹1,561.87 lakh in FY26
Mitsu Chem Plast Limited reported a 115% increase in net profit to ₹1,561.87 lakh for the financial year ended March 31, 2026. Revenue from operations rose 5.4% to ₹35,016.95 lakh. The Board has recommended a final dividend of ₹0.20 per equity share for the financial year.

*this image is generated using AI for illustrative purposes only.
Mitsu Chem Plast Limited reported a 115% increase in net profit to ₹1,561.87 lakh for the financial year ended March 31, 2026, driven by operational efficiency and strategic investments. Revenue from operations rose 5.4% to ₹35,016.95 lakh from ₹33,227.84 lakh in the previous year.
The Board of Directors, at its meeting held on May 02, 2026, recommended a final dividend of ₹0.20 per equity share of the face value of ₹10 each for the FY 2025-26. The dividend is subject to approval by shareholders at the ensuing Annual General Meeting.
Financial Performance
The company’s total income for the year stood at ₹35,084.56 lakh, up from ₹33,287.97 lakh in the previous year. Profit before tax increased to ₹2,127.44 lakh from ₹1,000.75 lakh. Tax expenses for the year amounted to ₹565.57 lakh.
| Particulars | FY 2025-26 (₹ in Lakhs) | FY 2024-25 (₹ in Lakhs) |
|---|---|---|
| Total Income | 35,084.56 | 33,287.97 |
| Profit Before Tax | 2,127.44 | 1,000.75 |
| Tax Expenses | 565.57 | 275.66 |
| Net Profit | 1,561.87 | 725.08 |
Earnings per share (EPS) improved to ₹11.50 from ₹5.39. The company’s equity share capital remained constant at ₹1,357.80 lakh.
Operational Highlights
The company’s growth was supported by the commencement of a new manufacturing unit (Unit 4) at Tarapur, Maharashtra, aimed at supporting growing operational requirements. The company’s product portfolio includes molded industrial packaging, hospital furniture parts, and infrastructural furniture.
Molded industrial packaging remained the largest revenue contributor, accounting for 83.88% of total turnover at ₹29,371.96 lakh. Hospital furniture parts contributed 13.23% of turnover at ₹4,631.23 lakh, while infrastructural and other segments made up the remaining 2.89%.
Outlook
Looking ahead to FY 2026-27, the company plans to focus on growth through capacity addition, R&D-led innovation, operational excellence, and expanding its presence in the export market. The company also aims to leverage its Furnastra brand to strengthen its position in the healthcare sector.
Historical Stock Returns for Mitsu Chem Plast
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.08% | -3.72% | -6.63% | +27.45% | +19.36% | -43.08% |
What is the expected timeline for the new Tarapur manufacturing unit (Unit 4) to reach full production capacity?
How will the company's increased focus on R&D and innovation specifically impact its product pipeline in the healthcare sector?
What are the primary target markets for the planned expansion into export markets, and what strategies will be employed to penetrate them?































